References
É. A. Markuryan, Zh. S. Arustamyan, S. S. Vasilyan, et al., Arm. Khim. Zh.,29, No. 7, 591 (1976).
G. K. Airapetyan, Zh. S. Arustamyan, O. S. Noravyan, et al., Arm. Khim. Zh.,40, No. 1, 40 (1987).
G. K. Airapetyan, A. P. Mikaelyan, É. A. Markaryan, et al., Arm. Khim. Zh.,41, No. 10, 629 (1988).
D. N. Harcourt and R. D. Waigh, J. Chem. Soc. (C), No. 5, 967 (1971).
O. M. Avakyan and O. S. Noravyan, Biol. Zh. Armen.,29, No. 1, 41 (1976).
N. V. Kaverina and Z. P. Senova, Methodological Recommendations on the Experimental Study of Preparations Proposed for Clinical Trials as Agents for Preventing and Treating Cardiac Rhythm Disturbances [in Russian], Moscow (1981), pp. 5–10.
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 28, No. 1, pp. 22–24, January, 1994.
Rights and permissions
About this article
Cite this article
Airapetyan, G.K., Mikaelyan, A.P., Markaryan, K.Z. et al. Isoquinoline derivatives. XXVIII. Synthesis of biologically active N-2-aryl-and N-3-alkylamino-2-alkanol derivatives of 3,3-dimethyl-6,7-dimethoxy-4-oxo[or 4-hydroxy]-1,2,3,4-tetrahydroisoquinolines. Pharm Chem J 28, 29–32 (1994). https://doi.org/10.1007/BF02218948
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02218948